Private Drug Coverage
Canadians benefit from effective and efficient private drug benefit plans.
More than 24 million Canadians benefit from private drug plan coverage. Private drug plans tend to cover more drugs more quickly when compared to public plans, which helps increase the value of the Canadian market for future pharmaceutical innovation.
Analysis & Reports
Cost Drivers: Analysis of Private Drug Plans in Canada 2021
The 2021 Cost Drivers report highlights the consistent annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
2016-2019 Analysis of Private Drug Claim Cost Drivers
The 2016–2019 Cost Drivers report highlights annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
Infographics & Data
Canadian Drug Access Pathway
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (732 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).
News
Pharmaceutical Benefits: Ensuring Value for Plan Sponsors
We need to work together to evolve the private market so that it continues to have the value of providing […]
Newsroom
Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.
About
Our member companies, which range from fledgling start-ups to established organizations, are revolutionizing healthcare through the discovery and development of […]
